Summary by Moomoo AI
CR Group L.P., a significant stakeholder in T2 Biosystems, Inc. [TTOO], reported acquiring additional shares of the company's common stock on February 14, 2024. The transactions were made indirectly through two entities. CRG Partners III (Cayman) Lev AIV I L.P. acquired 335,947 shares, while CRG Partners III Parallel Fund B LP added 488,273 shares to their holdings. Following these transactions, the total number of shares held by CR Group L.P. in T2 Biosystems amounts to 824,220. The acquisitions were made indirectly, signifying an increase in CR Group L.P.'s investment in the medical diagnostic company.